
KeyWise AI has developed Skye™, a 'fitness tracker for the brain' that passively assesses cognitive performance through keystroke behavior analysis. The system measures typing patterns to calculate a 'Clarity Score,' providing objective insights into cognitive functions like attention and processing speed. Backed by federal research funding from NIH and NIA, and peer-reviewed studies from universities like the University of Illinois and UCSD, Skye™ offers personalized feedback, alerts, and the ability to form private 'Care Circles' for support. Their technology is designed for various applications, including digital therapeutics, clinical trials, and digital fitness, aiming to replace subjective mental health assessments with objective measurements. The company was featured on ESPN SportsCenter for its work with student athletes.

KeyWise AI has developed Skye™, a 'fitness tracker for the brain' that passively assesses cognitive performance through keystroke behavior analysis. The system measures typing patterns to calculate a 'Clarity Score,' providing objective insights into cognitive functions like attention and processing speed. Backed by federal research funding from NIH and NIA, and peer-reviewed studies from universities like the University of Illinois and UCSD, Skye™ offers personalized feedback, alerts, and the ability to form private 'Care Circles' for support. Their technology is designed for various applications, including digital therapeutics, clinical trials, and digital fitness, aiming to replace subjective mental health assessments with objective measurements. The company was featured on ESPN SportsCenter for its work with student athletes.
Product: Skye — passive keystroke-based digital biomarker platform that measures cognition and mood
Founded / HQ: 2019, Chicago, IL
Science: NIH-sponsored research and multiple peer-reviewed publications
Team size: ~4 employees (reported)
Funding: Seed round announced 2022; reported total funding $0.00 (per snapshot) and investors include Merus Capital, 3CC, TSVC
Mental health measurement, cognitive monitoring, digital biomarkers
2019
Health technology / Digital health
Seed round reported April 4, 2022; investors listed include Merus Capital, 3CC (Third Culture Capital), and TSVC
“Investors reported include Merus Capital, 3CC (Third Culture Capital), TSVC, and additional investors shown on company materials such as Illinois Ventures, 11 Tribes Ventures, Conscience, Ginossar, and Ataraxia”